| Literature DB >> 32328568 |
Abstract
The deep inspiration (DI) maneuver entices a great deal of interest because of its ability to temporarily ease the flow of air into the lungs. This salutary effect of a DI is proposed to be mediated, at least partially, by momentarily increasing the operating length of airway smooth muscle (ASM). Concerningly, this premise is largely derived from a growing body of in vitro studies investigating the effect of stretching ASM by different magnitudes on its contractility. The relevance of these in vitro findings remains uncertain, as the real range of strains ASM undergoes in vivo during a DI is somewhat elusive. In order to understand the regulation of ASM contractility by a DI and to infer on its putative contribution to the bronchodilator effect of a DI, it is imperative that in vitro studies incorporate levels of strains that are physiologically relevant. This review summarizes the methods that may be used in vivo in humans to estimate the strain experienced by ASM during a DI from functional residual capacity (FRC) to total lung capacity (TLC). The strengths and limitations of each method, as well as the potential confounders, are also discussed. A rough estimated range of ASM strains is provided for the purpose of guiding future in vitro studies that aim at quantifying the regulatory effect of DI on ASM contractility. However, it is emphasized that, owing to the many limitations and confounders, more studies will be needed to reach conclusive statements.Entities:
Keywords: airway compliance; airway distensibility; airway wall; breathing maneuvers; strain
Year: 2019 PMID: 32328568 PMCID: PMC7164505 DOI: 10.1115/1.4042309
Source DB: PubMed Journal: J Eng Sci Med Diagn Ther ISSN: 2572-7966
Estimated strain on ASM during a DI from FRC to TLC
| Methods | Sample size and health status | State of ASM activation | Breathing maneuvers | Airways | Estimated ASM strain from FRC to TLC | Reference |
|---|---|---|---|---|---|---|
| 2 healthy | Baseline | A normal tidal breath from FRC and a tidal breath to TLC | All | 27.5% | [ | |
| 5 healthy | Baseline | Exercise, CO2 inhalation (3–6%) or both | All | 13.9% | [ | |
| 1 healthy | Baseline | Always from TLC, expired to a given lung volume, and then inhaled different allocated tidal volume to subsequently measure | All | 20.8% | [ | |
| Whole-body plethysmography | 24 healthy | Baseline | Panting at different lung volumes | All | Overall: 23.2% | [ |
| 3 healthy | Baseline | From FRC to different end-inspiratory volumes | All | 13.0% | [ | |
| Whole-body plethysmography | 12 healthy and 1 asthma | Baseline | Panting at different lung volumes while being seated upright | All | Healthy: 44.2% | [ |
| Bronchography | 10 patients | The airways were coated with Dionosil Oily | FRC and on full inspiration in supine position | The airways were divided in four groups according to their diameter: | >7 mm: 28% | [ |
| -Whole-body plethysmography -Two lateral pressure taps to measure upper Raw | 15 healthy, 7 asthma and 6 COPD | Baseline | Panting at different lung volumes while being seated upright | -All the airways from plethysmography -Upper airways from the lateral taps | Healthy: 34.3% | [ |
| 6 healthy | Baseline | From TLC down to different lung volumes | All | 34.3% | [ | |
| FOT at 4 Hz
| Baseline and after atropine (i.v., 1.2 mg) | -All | [ | |||
| Pulmonary conductance (flow/Δ | 10 healthy, 10 asthma and 10 emphysematous | -Baseline for all subjects | Interrupted deflation from TLC (after three maximal inspirations) | All | Healthy: 42.8% | [ |
| Fluoroscopy | 10 healthy and 35 cases of acquired tracheomalacia | Baseline | Suspended breathing and coughing | Trachea | Healthy: < 41.4% | [ |
| CT | 15 healthy | Baseline | FRC and TLC | Intrathoracic trachea | 8.1% | [ |
| Acoustic reflection technique | 8 healthy | Baseline | Slow maneuver from TLC to RV and back to TLC | -Extrathoracic trachea | -Extrathoracic trachea | [ |
| Acoustic reflection technique | 11 healthy and 11 cystic fibrosis | Baseline | Slow maneuver from FRC to TLC | The middle one third of the trachea | Healthy: 0.3% | [ |
| 10 healthy and 10 asthma | After albuterol | From RV and at 0.5 L increments up to maximum | All | Healthy: 20.7% | [ | |
| MRI | 13 healthy and 6 cases of tracheomalacia | Baseline | Forced inspiration, forced expiration and coughing | A 12-cm long tracheal segment downstream from 1 cm below the upper margin of the aortic arc | Healthy: 14.8% | [ |
| Pitot static probe | 14 healthy and 10 moderate-to-severe asthma | -Premedicated with 0.5 mg atropine i.m. 30 min before measurements and received topical anesthetic
| Maximal expiratory maneuvers | 5 positions:
| Healthy | [ |
| 16 healthy and 16 mild asthma | For asthmatics only: After albuterol (200 | 3 breathing regimens:
| All | 1-Healthy: 17.7% | [ | |
| HRCT | 9 healthy and 10 asthma | Baseline and following MCh using two protocols | FRC and TLC | Ranged in size from 1.2 to 12.2 mm (191 airways) in diameter for the first protocol and 1.6 to 11.4 mm (195 airways) in the second protocol | -Baseline | [ |
| 22 healthy and 35 mild-to-moderate asthma | -After albuterol (300 | TLC to FRC | All | Healthy: 11.7% | [ | |
| FOT at 8 Hz | 9 healthy and 14 asthma (classified as severe or mild-to-moderate according to baseline constriction and reactivity) | -Baseline | FRC and TLC | All | -Baseline | [ |
| FOT at 8 Hz | 7 healthy and 6 asthma | -Baseline | FRC and TLC | All | -Baseline | [ |
| FOT at 6 Hz | 18 healthy and 25 asthma | -After MCh (average of 1.8 and 95.5 | FRC and TLC | All | Healthy: 45.3% | [ |
| -FOT at 6 Hz
| 4 healthy and 3 mild asthma | Baseline | -FOT: TLC to FRC or FRC to TLC
| All | -FOT | [ |
| Multidetector row helical CT | 14 patients with respiratory illnesses | Baseline | End of DI, end of maximal expiration and during forced expiration | -Trachea at the level of aortic arc | Aortic arc: 18.8% | [ |
| FOT at 6 Hz | 19 healthy and 18 asthma | -Baseline | Slowly to TLC and then breathed at approximately tidal volume except that the end-expiratory lung volume had to decrease progressively after each breath until the volume was back to FRC. | All | -Baseline | [ |
| HRCT | 15 COPD | Baseline | RV and TLC | -233 airways ranging from 2.0 to 17.8 mm in diameter at RV
| All airways: 14.6% | [ |
| CT | 50 COPD | Baseline | At DI and at deep expiration | Right B1, right B10 and left B3 | Generation 3: 15.5% | [ |
| MDCT | 70 patients suspected of tracheobronchomalacia | Baseline | End of DI, end of maximal expiration and during a forced expiration | -At three levels in the trachea (cervical, upper, lower)
| Cervical trachea: 5.4% | [ |
| Dynamic cine multidetector CT and regular CT | 10 healthy and 40 cystic fibrosis | Baseline | -Forced expiration from TLC and coughing | A 2 cm-long segment of the trachea | Cystic fibrosis: 9.1% | [ |
| HRCT combined with esophageal pressure | 2 healthy | Baseline | TLC and FRC | 1.4–7.7 mm in diameter | 20.6–59% | [ |
| FOT at 8 Hz | 11 healthy and 15 COPD (moderate to severe) | -Baseline | FRC and TLC | All | -Baseline | [ |
| FOT at 6 Hz | 19 asthma | -Prior to and after a 12 weeks of inhaled corticosteroid + LABA (two puffs per day of fluticasone + salmeterol; 250/25 | Slowly to TLC and then breathed at approximately tidal volume except that the end-expiratory lung volume had to decrease progressively after each breath until the volume was back to FRC. | All | Prior treatment: | [ |
| FOT at 8 Hz | 34 healthy and 35 asthma | SABA and LABA were withheld for 6 and 24 h, respectively | End tidal inspiratory volume to TLC | All | Healthy: 23.9% | [ |
| HRCT combined with esophageal pressure | 9 asthma | -Baseline | TLC and FRC | Airways of 1.1–10.7 mm internal diameter | -Baseline | [ |
| aOCT | 10 healthy, 16 asthma, 9 COPD and 8 bronchiectasis | -Relaxed with salbutamol (5 mg)
| Airway pressure from -10–20 cmH2O | Airway generations 0, 1, 3, 4 and 5 | -Generation 0
| [ |
| HRCT | 15 asthma | -Baseline | FRC and TLC (breath holding ∼24 s) | Airways of 2.2–17.4 mm internal diameter | Baseline: | [ |
| CT | 44 COPD with α-1-antitrypsin | -Relaxed with salbutamol (5 mg) and ipratropium bromide (500 mg) | TLC and FRC | 3 segmental bronchi | RB1: 6.0% | [ |
| HRCT | 46 healthy smokers, 23 COPD 2-AP, 23 COPD 2-EP, 23 COPD 4-AP and 23 COPD 4-EP.
| May or may not have been treated with albuterol | End-tidal expiration and TLC | The right apical bronchi (RB1)
| -RB1 third | [ |
| Acoustic reflection technique | 20 healthy and 20 cystic fibrosis | Baseline | During spontaneous breathing and at forced inspiration | Trachea | -Trachea | [ |
| FOT at 5 Hz | 28 patients with hematological malignancies before and after allogeneic haematopoietic stem-cell transplantation (HSCT) | -Baseline | FRC and TLC | All | -Baseline | [ |
| HRCT | 12 asthma and 8 COPD | Baseline | FRC and TLC | Airways of 2–23.1 mm internal diameter | 5–29% | [ |
| HRCT | 961 smokers or ex-smokers with normal lung function | Baseline | Supine, during breath holding, aiming for TLC after 3 DIs, annually for up to 5 years | All measurable airways from generation 0 to 7 and all segmental bronchi | Generation 0: 16.1% | [ |
| HRCT | 12 cystic fibrosis with the G551D-CFTR mutation | -Before and after 48 h of treatment with ivacaftor | Supine RV and TLC during breath holding preceded by 3 DIs | Airways with internal diameter of 2.4–20.8 mm | -Before ivacaftor | [ |
| HRCT | 9 healthy and 19 asthma | -Baseline
| FRC and TLC | Airway generations 2–6 | -Baseline | [ |
| FOT at 5 Hz | Healthy ( | Baseline | Slowly to TLC and then breathed at approximately tidal volume except that the end-expiratory lung volume had to decrease progressively after each breath until the volume was back to RV. | All | 32.0% | [ |
| HRCT | Asthma | After the PC20 of MCh | Mean lung volume to TLC in supine position | Trachea to airway generation 5 | Trachea: 10.8% | [ |
Note: aOCT—anatomical optical coherence tomography, COPD—chronic obstructive pulmonary disease, DI—deep inspiration, FEV1—forced expiratory volume in 1 s, FOT—forced oscillation technique, FRC—functional residual capacity, HRCT—high-resolution computed tomography, LABA---long-acting β2-agonist, MCh—methacholine, PC20—the provocative concentration of methacholine causing a 20% decline in FEV1, Raw—airway resistance, RV—residual volume, SABA---short-acting β2-agonist, SBNW---single breath nitogen washout, TLC—total lung capacity, VC---vital capacity, and V—dead volume.
It was assumed that ASM is arranged orthogonally in relation to the long axis of the airways.
It was assumed that the volume of the airways expands isotropically during an increase in lung volume from FRC to TLC.
It was assumed that the changes in resistance are inversely proportional to the changes in airway luminal radius at the fourth power.
Fig. 1The changes in luminal geometry overestimate the stretch the ASM undergoes during a deep inspiration (DI). The schematic illustrates a normal (left) and an asthmatic (right) airways at FRC and after a DI to TLC. The dimensions are zoomed but at scale to an average airway of the ten generation. The springs represent lung recoil. They are stretched at TLC relative to FRC. The arrow at approximately 2 o'clock is the radius (in mm) of the airway lumen (r). The arrow at approximately 1 o'clock is the radius up to the middle of the airway smooth muscle layer (r). The material composing the airway wall was considered inextensible. Notice the thinning of the airway wall when the lungs are inflating to TLC. It this schematic it was assumed that the luminal geometry at FRC was equal between normal and asthmatic. It was further assumed that the DI was increasing luminal radius by 25% in both normal and asthmatic, so that the luminal geometry at TLC was also equal between normal and asthmatic. The schematic demonstrates that a 25% increase of luminal perimeter (P) only causes a 21.2% increase of the perimeter at the middle of the ASM layer (P). This effect is further amplified in asthmatic because of a thicker airway wall (25 versus 18.2%). The mathematics is developed in the middle. Other abbreviations: AAW—area of the airway wall from the lumen to the middle of the ASM layer, A—luminal area, A—area internal to the middle of the ASM layer, and %Δ—change in percentage.
Fig. 2Imagine an airway cut open longitudinally and unfolded to form the rectangle on top (a). The letter a represents the airway perimeter and, in this example, is set to 10 mm. The letter b is the airway longitudinal distance covered by the ASM bundle going around the full circumference of the airway. Finally, the letter c represents the length of the ASM bundle and, in this example, is set at an angle 75 deg off the long axis of the airway. Using trigonometry, b and c can be determined. Now imagine that this airway is stretched radially to increase its perimeter by 25%. On the flattened airway shown in (a), this would increase the height of the rectangle by 25% without changing its length (b). Compared to (a), the length of a would increase by 25%, the length of b would remain unchanged and the length of c would increase by 23.5%. The angle of c would also change to 77.9 deg. Therefore, a radial stretch to the airway increasing its perimeter by 25% is expected to strain the ASM bundle by only 23.5%. Now imagine that the airway length is also strained by 25%. On the flattened airway shown in (b), this would increase the length of the rectangle by 25% (c). Compared to (a), the length of a, b, and c would all increase by 25%. In contrast to (b), the angle of c would remain unchanged. Therefore, when both radial and longitudinal strains are applied simultaneously at the same magnitude on an airway, the strain on the ASM is also of this magnitude.